Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, Youil R.
Palker T, et al. Among authors: szymkowiak c.
Virus Res. 2004 Oct;105(2):183-94. doi: 10.1016/j.virusres.2004.05.009.
Virus Res. 2004.
PMID: 15351492